The potential mechanism of BVA in Parkinson’s disease works by reinstating both brain TNF-α and IL-1β in brain tissues, inducing a significant elevation in caspase-3 activity and elevating the expression of apoptosis-related genes such as caspase-3 and Bax [46,48]. This evidence concerns the gene CASP3 and Parkinson disease.